Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp

Conditions:   Candidiasis;   AspergillosisIntervention:   Drug: MicafunginSponsor:   Astellas Pharma China, Inc.Terminated - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials